These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35891202)

  • 1. GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A
    Palmieri E; Kis Z; Ozanne J; Di Benedetto R; Ricchetti B; Massai L; Carducci M; Oldrini D; Gasperini G; Aruta MG; Rossi O; Kontoravdi C; Shah N; Mawas F; Micoli F
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against
    Raso MM; Gasperini G; Alfini R; Schiavo F; Aruta MG; Carducci M; Forgione MC; Martini S; Cescutti P; Necchi F; Micoli F
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260067
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models.
    Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Oldrini D; Pitirollo O; Gasperini G; Balocchi C; Bechi N; Brunelli B; Piccioli D; Adamo R
    Front Immunol; 2021; 12():719315. PubMed ID: 34594333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of
    Di Benedetto R; Mancini F; Caradonna V; Aruta MG; Giannelli C; Rossi O; Micoli F
    Front Mol Biosci; 2023; 10():1284515. PubMed ID: 38046812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of a Glycoconjugate Vaccine against Group A
    Di Benedetto R; Mancini F; Carducci M; Gasperini G; Moriel DG; Saul A; Necchi F; Rappuoli R; Micoli F
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus.
    Pitirollo O; Di Benedetto R; Henriques P; Gasperini G; Mancini F; Carducci M; Massai L; Rossi O; Volbeda AG; Codée JDC; Berlanda Scorza F; Moriel DG; Necchi F; Lay L; Adamo R; Micoli F
    Carbohydr Polym; 2023 Jul; 311():120736. PubMed ID: 37028871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against
    Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing
    Mancini F; Caradonna V; Alfini R; Aruta MG; Vitali CG; Gasperini G; Piccioli D; Berlanda Scorza F; Rossi O; Micoli F
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of O-Antigen Chain Length Regulation on the Immunogenicity of
    Gasperini G; Raso MM; Arato V; Aruta MG; Cescutti P; Necchi F; Micoli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards a glycoconjugate vaccine against Group A Streptococcus.
    Burns K; Dorfmueller HC; Wren BW; Mawas F; Shaw HA
    NPJ Vaccines; 2023 Mar; 8(1):48. PubMed ID: 36977677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines.
    Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Palmieri E; Balocchi C; Gasperini G; Brunelli B; Costantino P; Adamo R; Piccioli D; Saul A
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32957610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB.
    Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A
    PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Systemic Humoral Immune Response Induced in Mice by Generalized Modules for Membrane Antigens (GMMA) Is Associated with Affinity Maturation and Isotype Switching.
    Piccioli D; Buricchi F; Bacconi M; Bechi N; Galli B; Ferlicca F; Luzzi E; Cartocci E; Marchi S; Romagnoli G; Alfini R; Di Benedetto R; Gallorini S; Savino S; Brunelli B; Bartolini E; Micoli F
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines.
    Rossi O; Aruta MG; Acquaviva A; Mancini F; Micoli F; Necchi F
    Methods Protoc; 2020 Aug; 3(3):. PubMed ID: 32878036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine.
    Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R
    Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle-based vaccine platform, for efficient viral antigen delivery.
    Hu K; Palmieri E; Samnuan K; Ricchetti B; Oldrini D; McKay PF; Wu G; Thorne L; Fooks AR; McElhinney LM; Goharriz H; Golding M; Shattock RJ; Micoli F
    J Extracell Vesicles; 2022 Nov; 11(11):e12247. PubMed ID: 36377074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group A
    Wang S; Zhao Y; Wang G; Feng S; Guo Z; Gu G
    ACS Infect Dis; 2020 Feb; 6(2):281-290. PubMed ID: 31872763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.